Several hypotheses have been made, including the weight gain effect of concomitant antidiabetic drugs (e.g., insulin and sulfanilureas), reduced dietary adherence due to fear of hypoglycemia, reduced glycosuria achieved by improved glycemic compensation, and alterations in the microbiome in subjects with DM2.37 The gene discussed is INS; the disease is Hypoglycemia.